Trial Profile
Clinical Trials Insight: 700056268
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 18 May 2010
Price :
$35
*
At a glance
- Drugs Escitalopram (Primary) ; Paroxetine
- Indications Major depressive disorder
- Focus Registrational; Therapeutic Use
- Sponsors Mochida Pharmaceutical
- 18 May 2010 New trial record
- 17 May 2010 According to a Lundbeck A/S media release, based on the positive results of this trial, Mochida Pharmaceuticals plans to file regulatory approval for escitalopram by the first quarter 2011.